Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.21.2
Consolidated Statements of Cash Flows - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Sep. 30, 2020
Cash flows from operating activities:          
Net loss $ (1,529,905) $ (904,367) $ (4,475,305) $ (3,296,005)  
Adjustments to reconcile net loss to cash used in operating activities:          
Depreciation 799 1,765 1,788 5,466  
Stock-based compensation     372,196 680,231  
Decrease to fair value of derivative     (108,944) (719,831)  
Inventory obsolescence charge     181,988 95,637  
Gain on forgiveness of loan     (178,229) 0  
(Increase) decrease in:          
Inventory     (42,215) (726,586)  
Prepaid expenses and other current assets     (163,135) 196,399  
Increase (decrease) in:          
Accounts payable     (64,853) (231,254)  
Accrued interest     110,956 0  
Accrued expenses and other liabilities     (80,324) 4,755  
Net cash used in operating activities     (4,446,077) (3,991,188)  
Cash flows from investing activities:          
Purchases of property and equipment     (3,275) (2,455)  
Net cash used in investing activities     (3,275) (2,455)  
Cash flows from financing activities:          
Proceeds received from convertible notes     1,050,000 550,000  
Proceeds received from PPP loan     0 176,300  
Proceeds from issued common stock and warrants, net of financing costs     6,219,233 2,167,162  
Proceeds from exercise of warrants     0 932,728  
Net cash provided by financing activities     7,269,233 3,826,190  
Net increase (decrease) in cash     2,819,881 (167,453)  
Cash, beginning of year     959,309 2,180,329 $ 2,180,329
Cash, end of period $ 3,779,190 $ 2,012,876 3,779,190 2,012,876 $ 959,309
Non-cash financing activities:          
Issuance of restricted stock for services     103,750 0  
Series J Warrants cost     $ 0 $ 219,737